亚解离剂量氯胺酮与吗啡用于院前镇痛的非劣效性随机对照试验方案
本研究为多中心、单盲、随机对照试验,计划纳入院前中度至重度急性创伤或非创伤性疼痛成人患者,随机接受静脉推注氯胺酮或吗啡。主要结局为给药前至给药后30分钟数字评定量表疼痛评分平均变化的组间差异,旨在评估亚解离剂量氯胺酮镇痛的疗效与安全性。
要点
- 院前中重度疼痛成人随机接受静脉氯胺酮或吗啡镇痛。
- 主要终点为给药前至30分钟后NRS评分平均变化的组间差异。
- 亚解离剂量氯胺酮保留保护性气道反射,可能减少阿片暴露。
核心结论
- 该试验旨在评估亚解离剂量氯胺酮用于院前创伤与非创伤性疼痛镇痛是否非劣于吗啡。
研究设计与样本
- 多中心、单盲、随机对照试验,连续纳入院前中重度急性创伤或非创伤性疼痛成人患者,NRS评分≥5。
关键数值与推荐
- 主要结局为给药前至给药后30分钟NRS疼痛评分平均变化的组间差异。
- 纳入标准为院前中重度急性非创伤性或创伤性疼痛,定义为NRS评分≥5。
临床怎么用
- 若证实有效,可为院前镇痛提供非阿片替代方案,减少阿片暴露及成瘾风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute pain is a common condition among prehospital patients and prompt management is pivotal. Opioids are the most frequently analgesics used in the prehospital setting. However, opioids are highly addictive, and some patients may develop opioid dependence, even when they are exposed to brief opioid treatments. Therefore, alternative non-opioid analgesia should be developed to manage pain in the prehospital setting. Used at subdissociative doses, ketamine, a noncompetitive N-methyl-D-aspartate and glutamate receptor antagonist, provides analgesic effects accompanied by preservation of protective airway reflexes. In this context, we will carry out a randomized controlled, open-label, multicenter trial to compare a subdissociative dose of ketamine to morphine to provide pain relief in the prehospital setting, in patients with traumatic and non-traumatic pain. METHODS/DESIGN: This will be a multicenter, single-blind, randomized controlled trial. Consecutive adults will be enrolled in the prehospital setting if they experience moderate to severe, acute, non-traumatic and traumatic pain, defined as a numeric rating scale score greater or equal to 5. Patients will be randomized to receive ketamine or morphine by intravenous push. The primary outcome will be the between-group difference in mean change in numeric rating scale pain scores measured from the time before administration of the study medication to 30 min later. DISCUSSION: This upcoming randomized clinical trial was design to assess the efficacy and safety of ketamine, an alternative non-opiate analgesia, to manage non-traumatic and traumatic pain in the prehospital setting. We aim to provide evidence to change prescribing practices to reduce exposition to opioids and the subsequent risk of addiction. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03236805 . Registered on 2 August 2017.
引用
- Le Cornec C, Lariby S, Brenckmann V, et al. Is intravenously administered, subdissociative-dose KETAmine non-inferior to MORPHine for prehospital analgesia (the KETAMORPH study): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29716637. doi:10.1186/s13063-018-2634-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。